Stay updated on Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial
Sign up to get notified when there's something new on the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page.

Latest updates to the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2; the study page remains a 403 Forbidden error page.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAn NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, and the site revision changes from v3.7.1 to v3.7.2. The clinical trial record remains inaccessible behind a 403 error.SummaryDifference1%

- Check33 days agoChange DetectedThe 403 error page footer now shows revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check47 days agoChange DetectedThe study page now presents a 403 Forbidden error with a minimal header where the study details would normally appear.SummaryDifference24%

- Check54 days agoChange DetectedRevision: v3.7.0 was added, replacing the previous Revision: v3.6.6 and signaling an update to the page's revision history.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page history now shows Revision: v3.6.6 as the latest update and removes Revision: v3.6.5.SummaryDifference0.0%

Stay in the know with updates to Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page.